Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Evaluation of HIF-1 inhibitors as anticancer agents — Gregg L. Friedman (2007) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Evaluation of HIF-1 inhibitors as anticancer agents
Shared by
Gregg L. Friedman
Johns Hopkins University
Evaluation of HIF-1 inhibitors as anticancer agents
Article
2007
en
Related publications
Article
2006
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre
,
Guido Guido Kroemer
,
Éric Raymond
Article
2013
Synthesis and biological evaluation of some novel tetrahydroquinolines as anticancer and antimicrobial agents
Hassan M. Faidallah
,
Alaa A. Saqer
,
Khalid A. Alamry
,
Khalid Ali Khan
,
Abdullah Mohamed Asiri
Authors
Gregg L. Friedman
Johns Hopkins University
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2004
Histone deacetylase inhibitors: Understanding a new wave of anticancer agents
Ana Villar‐Garea
,
Manel Esteller
Editorial Material
2014
Immunogenic cell death inducers as anticancer agents
Oliver Kepp
,
Laura Senovilla
,
Guido Guido Kroemer
Article
2003
Synthesis of 3‘- and 5‘-Nitrooxy Pyrimidine Nucleoside Nitrate Esters: “Nitric Oxide Donor” Agents for Evaluation as Anticancer and Antiviral Agents
Ebrahim Naimi
,
Aihua Zhou
,
Panteha Khalili
,
Leonard I. Wiebe
,
Jan Balzarini
,
De Clercq Erik
,
Edward E. Knaus
Discussion(0)
No comments yet. Be the first to comment.